Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
| DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
|
10-hydroxycamptothecin + Chlorambucil
|
DC9M2Y5
|
10-hydroxycamptothecin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
10-hydroxycamptothecin + Chlorambucil
|
DCX9JDL
|
10-hydroxycamptothecin
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
10-hydroxycamptothecin + Chlorambucil
|
DCQ9JNR
|
10-hydroxycamptothecin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
10-hydroxycamptothecin + Chlorambucil
|
DCRCD4C
|
10-hydroxycamptothecin
|
Glioma (Cell Line: SF-539)
|
[3] |
|
10-hydroxycamptothecin + Chlorambucil
|
DCYK5KK
|
10-hydroxycamptothecin
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
ABIRATERONE + Chlorambucil
|
DCRSTKA
|
ABIRATERONE
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
ABIRATERONE + Chlorambucil
|
DCLNFHW
|
ABIRATERONE
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
|
ABIRATERONE + Chlorambucil
|
DCONF5A
|
ABIRATERONE
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
Altretamine + Chlorambucil
|
DCPYE2D
|
Altretamine
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Altretamine + Chlorambucil
|
DCIXDMB
|
Altretamine
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCM3A6C
|
Aminolevulinic Acid Hydrochloride
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DC2WM90
|
Aminolevulinic Acid Hydrochloride
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCZEK80
|
Aminolevulinic Acid Hydrochloride
|
Adenocarcinoma (Cell Line: A549)
|
[5] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCTM492
|
Aminolevulinic Acid Hydrochloride
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCOV81U
|
Aminolevulinic Acid Hydrochloride
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
Amonafide + Chlorambucil
|
DCQPRFV
|
Amonafide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Amonafide + Chlorambucil
|
DCG08PA
|
Amonafide
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Amonafide + Chlorambucil
|
DCZIQU8
|
Amonafide
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Amonafide + Chlorambucil
|
DCDKKN3
|
Amonafide
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Anamorelin + Chlorambucil
|
DCAXTZG
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Anastrozole + Chlorambucil
|
DCE00J5
|
Anastrozole
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Anastrozole + Chlorambucil
|
DCLTU15
|
Anastrozole
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
Anastrozole + Chlorambucil
|
DC1IS9I
|
Anastrozole
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Anastrozole + Chlorambucil
|
DCJPDRC
|
Anastrozole
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Anastrozole + Chlorambucil
|
DCAV8GE
|
Anastrozole
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Anastrozole + Chlorambucil
|
DCD5OY8
|
Anastrozole
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Anastrozole + Chlorambucil
|
DC1B840
|
Anastrozole
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Anastrozole + Chlorambucil
|
DCU0DS0
|
Anastrozole
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Anastrozole + Chlorambucil
|
DC87KTP
|
Anastrozole
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Anastrozole + Chlorambucil
|
DC8FQCO
|
Anastrozole
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Arfolitixorin + Chlorambucil
|
DCVDCRG
|
Arfolitixorin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Arfolitixorin + Chlorambucil
|
DCEKV6C
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Arfolitixorin + Chlorambucil
|
DCL69VX
|
Arfolitixorin
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Artemisinin + Chlorambucil
|
DCJWYC5
|
Artemisinin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Azacitidine + Chlorambucil
|
DCRAAM3
|
Azacitidine
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Azacitidine + Chlorambucil
|
DCA4UQX
|
Azacitidine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Azacitidine + Chlorambucil
|
DCXEP0F
|
Azacitidine
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCNK532
|
Bendamustine hydrochloride
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Bendamustine hydrochloride + Chlorambucil
|
DC3FG6G
|
Bendamustine hydrochloride
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Bendamustine hydrochloride + Chlorambucil
|
DC7YU36
|
Bendamustine hydrochloride
|
Renal cell carcinoma (Cell Line: UO-31)
|
[3] |
|
Bendamustine hydrochloride + Chlorambucil
|
DC3IQPK
|
Bendamustine hydrochloride
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCO57MN
|
Bendamustine hydrochloride
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCG1O4R
|
Bendamustine hydrochloride
|
Adenocarcinoma (Cell Line: A549)
|
[5] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCL08C1
|
Bendamustine hydrochloride
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCBYKFW
|
Bendamustine hydrochloride
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCLL6FR
|
Bendamustine hydrochloride
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
Bendamustine hydrochloride + Chlorambucil
|
DCT7G19
|
Bendamustine hydrochloride
|
Prostate carcinoma (Cell Line: PC-3)
|
[5] |
|
BIO-300 + Chlorambucil
|
DC956IJ
|
BIO-300
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
|
Bleomycin + Chlorambucil
|
DCJ6RGM
|
Bleomycin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Bleomycin + Chlorambucil
|
DCHYL67
|
Bleomycin
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Bleomycin + Chlorambucil
|
DCYE2HW
|
Bleomycin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Bleomycin + Chlorambucil
|
DCFOTZH
|
Bleomycin
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Bleomycin + Chlorambucil
|
DCZ97Q9
|
Bleomycin
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Bleomycin + Chlorambucil
|
DCO3W64
|
Bleomycin
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Bleomycin + Chlorambucil
|
DCN10V5
|
Bleomycin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
|
Bleomycin + Chlorambucil
|
DC7R5Y7
|
Bleomycin
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Bleomycin + Chlorambucil
|
DC96CWF
|
Bleomycin
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
|
Bleomycin + Chlorambucil
|
DCJZAVO
|
Bleomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
Bortezomib + Chlorambucil
|
DCCD8ER
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Brincidofovir + Chlorambucil
|
DCQYQ8N
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Busulfan + Chlorambucil
|
DC4Y07M
|
Busulfan
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Busulfan + Chlorambucil
|
DCP6BV9
|
Busulfan
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Busulfan + Chlorambucil
|
DCODFUU
|
Busulfan
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Busulfan + Chlorambucil
|
DCKSVR1
|
Busulfan
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
|
Busulfan + Chlorambucil
|
DCJYGH2
|
Busulfan
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Busulfan + Chlorambucil
|
DCWZ632
|
Busulfan
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[3] |
|
Busulfan + Chlorambucil
|
DCA832U
|
Busulfan
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCZ4MAF
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCJ85Q0
|
Cabazitaxel
|
Adenocarcinoma (Cell Line: SW-620)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCGXB00
|
Cabazitaxel
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCQQKZY
|
Cabazitaxel
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCM5OYH
|
Cabazitaxel
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCIPKWS
|
Cabazitaxel
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DC3IRP0
|
Cabazitaxel
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCYL3S0
|
Cabazitaxel
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCXYHE2
|
Cabazitaxel
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCMHNC7
|
Cabazitaxel
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCD71KK
|
Cabazitaxel
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCAWV7O
|
Cabazitaxel
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCD9AFB
|
Cabazitaxel
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DC2X3QA
|
Cabazitaxel
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCRN59A
|
Cabazitaxel
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
|
Cabazitaxel + Chlorambucil
|
DCWAK7L
|
Cabazitaxel
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Cabazitaxel + Chlorambucil
|
DCSKFB0
|
Cabazitaxel
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Chlorambucil + Aprepitant
|
DC256RW
|
Aprepitant
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Sertraline
|
DCYPC7C
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Dantrolene
|
DCQPY7I
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Diethylcarbamazine
|
DCDTKX5
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Imipramine
|
DCNWFYV
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Arsenic trioxide
|
DCL15NA
|
Arsenic trioxide
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Chlorambucil + Arsenic trioxide
|
DCZ2MNU
|
Arsenic trioxide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Chlorambucil + Arsenic trioxide
|
DC0H93M
|
Arsenic trioxide
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Chlorambucil + Arsenic trioxide
|
DCXY8AG
|
Arsenic trioxide
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Chlorambucil + BHV-0223
|
DCBD8CA
|
BHV-0223
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCUJFEI
|
Ifosfamide
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCMV2ML
|
Ifosfamide
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCHY6MU
|
Ifosfamide
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DC4QRQ0
|
Ifosfamide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCQGMDZ
|
Ifosfamide
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCJUCIC
|
Ifosfamide
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCUETCM
|
Ifosfamide
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DCZF8NT
|
Ifosfamide
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Chlorambucil + Ifosfamide
|
DC52SWE
|
Ifosfamide
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Chlorambucil + Fluspirilene
|
DCEGX7O
|
Fluspirilene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + PHA-739358
|
DCOFGOG
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + BIO-300
|
DCXZQ8V
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Niclosamide
|
DCGRCXA
|
Niclosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + PF-02545920
|
DC2BBSP
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Tiagabine
|
DCOI4VH
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Bortezomib
|
DCTB7OI
|
Bortezomib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Chlorambucil + Cisplatin
|
DC7IMEH
|
Cisplatin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Chlorambucil + Cisplatin
|
DCLEC9I
|
Cisplatin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Chlorambucil + Cisplatin
|
DCT7ATY
|
Cisplatin
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Chlorambucil + Brincidofovir
|
DCW2BW5
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Mycophenolic acid
|
DCIQ5SR
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Doxorubicin
|
DC68WQ2
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Auranofin
|
DCCWSNN
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Vorinostat
|
DCBI42G
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Metaxalone
|
DCOQ5Z7
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Cytarabine
|
DCWGZ5G
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Chlorambucil + Ixabepilone
|
DCFTAS2
|
Ixabepilone
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Chlorambucil + Ifosfamide
|
DCIUCWV
|
Ifosfamide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Chlorambucil + Ifosfamide
|
DCW54O5
|
Ifosfamide
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Crizotinib + Chlorambucil
|
DC3JXB2
|
Crizotinib
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Crizotinib + Chlorambucil
|
DCUUUQB
|
Crizotinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Crizotinib + Chlorambucil
|
DCPBKL9
|
Crizotinib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Crizotinib + Chlorambucil
|
DCC7UAK
|
Crizotinib
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Cyclophosphamide + Chlorambucil
|
DCEMLR7
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Cyclophosphamide + Chlorambucil
|
DCE7LFI
|
Cyclophosphamide
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Cyclophosphamide + Chlorambucil
|
DCRNV0K
|
Cyclophosphamide
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Cyclophosphamide + Chlorambucil
|
DCLUICT
|
Cyclophosphamide
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
Cyclophosphamide + Chlorambucil
|
DCIK8CD
|
Cyclophosphamide
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Cyclophosphamide + Chlorambucil
|
DCECI0G
|
Cyclophosphamide
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Dacarbazine + Chlorambucil
|
DCD41DO
|
Dacarbazine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Dacarbazine + Chlorambucil
|
DCMI0PH
|
Dacarbazine
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DCXQ7DS
|
Dacarbazine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DC5TCGP
|
Dacarbazine
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DC6TWHU
|
Dacarbazine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DCQBTV5
|
Dacarbazine
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DCRSOT2
|
Dacarbazine
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DCTKD5H
|
Dacarbazine
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Dacarbazine + Chlorambucil
|
DC0XGTE
|
Dacarbazine
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Dactinomycin + Chlorambucil
|
DCBIF7F
|
Dactinomycin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[5] |
|
Dactinomycin + Chlorambucil
|
DCSRGUS
|
Dactinomycin
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Dasatinib + Chlorambucil
|
DCW0Z2P
|
Dasatinib
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Dasatinib + Chlorambucil
|
DCDV21Q
|
Dasatinib
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Dasatinib + Chlorambucil
|
DCEIM4L
|
Dasatinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[3] |
|
Dasatinib + Chlorambucil
|
DCN8W2S
|
Dasatinib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
|
Desoxycorticosterone pivalate + Chlorambucil
|
DCSOJVZ
|
Desoxycorticosterone pivalate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Dexrazoxane + Chlorambucil
|
DCKMCNW
|
Dexrazoxane
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
DFN-15 + Chlorambucil
|
DCGILBE
|
DFN-15
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
DFN-15 + Chlorambucil
|
DCSAC1I
|
DFN-15
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
|
DFN-15 + Chlorambucil
|
DCOE0JA
|
DFN-15
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Diphenidol + Chlorambucil
|
DCR57TZ
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Docetaxel + Chlorambucil
|
DCUMRAO
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Docetaxel + Chlorambucil
|
DC8CK60
|
Docetaxel
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Endoxifen + Chlorambucil
|
DCQJI1K
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Epirubicin + Chlorambucil
|
DCQNLT3
|
Epirubicin
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
ER819762 + Chlorambucil
|
DCHX95W
|
ER819762
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
ER819762 + Chlorambucil
|
DC6TKNO
|
ER819762
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
|
ER819762 + Chlorambucil
|
DC00IU9
|
ER819762
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
Estramustine + Chlorambucil
|
DC44JQF
|
Estramustine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Estramustine + Chlorambucil
|
DCMD0I5
|
Estramustine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Estramustine + Chlorambucil
|
DC5MRX7
|
Estramustine
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Estramustine + Chlorambucil
|
DCPA30O
|
Estramustine
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Estramustine + Chlorambucil
|
DCLWALV
|
Estramustine
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Estramustine + Chlorambucil
|
DCJCSS9
|
Estramustine
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
|
Estramustine + Chlorambucil
|
DC3VDT9
|
Estramustine
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Estramustine + Chlorambucil
|
DCLFIAK
|
Estramustine
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
|
Fludarabine + Chlorambucil
|
DCSYI0B
|
Fludarabine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Fludarabine + Chlorambucil
|
DCGL67U
|
Fludarabine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Fludarabine + Chlorambucil
|
DCK9U2O
|
Fludarabine
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Fludarabine + Chlorambucil
|
DCUDMTI
|
Fludarabine
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
|
Fludarabine + Chlorambucil
|
DCZ9N5U
|
Fludarabine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
FORMESTANE + Chlorambucil
|
DCOEHCU
|
FORMESTANE
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCV98QQ
|
FORMESTANE
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCS3MSA
|
FORMESTANE
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCH2DNP
|
FORMESTANE
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DC2SPFR
|
FORMESTANE
|
Glioma (Cell Line: SF-295)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCKHO8U
|
FORMESTANE
|
Glioma (Cell Line: SF-539)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCNO7UZ
|
FORMESTANE
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DC9NCNE
|
FORMESTANE
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
FORMESTANE + Chlorambucil
|
DCGQMCI
|
FORMESTANE
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Fulvestrant + Chlorambucil
|
DCCHC9R
|
Fulvestrant
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DCLDDO6
|
Fulvestrant
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DC420QR
|
Fulvestrant
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DCDE88O
|
Fulvestrant
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DCJ5UVU
|
Fulvestrant
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DC42W7T
|
Fulvestrant
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DC1GZ1V
|
Fulvestrant
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DC6C050
|
Fulvestrant
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Fulvestrant + Chlorambucil
|
DC0EW6M
|
Fulvestrant
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Fulvestrant + Chlorambucil
|
DC6GLB1
|
Fulvestrant
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Gefitinib + Chlorambucil
|
DCQF28F
|
Gefitinib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Gefitinib + Chlorambucil
|
DCTQJVO
|
Gefitinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Gefitinib + Chlorambucil
|
DCWGZHC
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Gefitinib + Chlorambucil
|
DCNCODO
|
Gefitinib
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Gefitinib + Chlorambucil
|
DCILG8G
|
Gefitinib
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Gefitinib + Chlorambucil
|
DCOGGUP
|
Gefitinib
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Gefitinib + Chlorambucil
|
DCK5ED9
|
Gefitinib
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Gefitinib + Chlorambucil
|
DCTRSJ5
|
Gefitinib
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Guanfacine + Chlorambucil
|
DC3P025
|
Guanfacine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Hepzato + Chlorambucil
|
DC0JMER
|
Hepzato
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
|
Hepzato + Chlorambucil
|
DCG3899
|
Hepzato
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
|
Hepzato + Chlorambucil
|
DCCHQEL
|
Hepzato
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
|
Hyodeoxycholic acid + Chlorambucil
|
DCQGKCC
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Imatinib + Chlorambucil
|
DC3HYT7
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Imatinib + Chlorambucil
|
DCH41QO
|
Imatinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Imatinib + Chlorambucil
|
DC138M0
|
Imatinib
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Imatinib + Chlorambucil
|
DCFXGLG
|
Imatinib
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Imatinib + Chlorambucil
|
DCLNJXQ
|
Imatinib
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Indazole derivative 5 + Chlorambucil
|
DCEB2W6
|
Indazole derivative 5
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Indazole derivative 5 + Chlorambucil
|
DC61HV7
|
Indazole derivative 5
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
|
Indazole derivative 5 + Chlorambucil
|
DC3RID1
|
Indazole derivative 5
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
Indazole derivative 5 + Chlorambucil
|
DC2W54V
|
Indazole derivative 5
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
|
Isoniazid + Chlorambucil
|
DCG61LO
|
Isoniazid
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Isoniazid + Chlorambucil
|
DC67EU6
|
Isoniazid
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Isoniazid + Chlorambucil
|
DC2MUQO
|
Isoniazid
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCKTQSG
|
Isoniazid
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCXOYMY
|
Isoniazid
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCTXFDY
|
Isoniazid
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCO12LL
|
Isoniazid
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
Isoniazid + Chlorambucil
|
DC1HO8O
|
Isoniazid
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCN8WYO
|
Isoniazid
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Isoniazid + Chlorambucil
|
DC80FZ6
|
Isoniazid
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Isoniazid + Chlorambucil
|
DCCIG0C
|
Isoniazid
|
Renal cell carcinoma (Cell Line: UO-31)
|
[3] |
|
IT-141 + Chlorambucil
|
DCD7169
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Itraconazole + Chlorambucil
|
DCYKG6G
|
Itraconazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
JNK-IN-8 + Chlorambucil
|
DCB0S0W
|
JNK-IN-8
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
JNK-IN-8 + Chlorambucil
|
DC2GVQJ
|
JNK-IN-8
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Lapatinib + Chlorambucil
|
DC3REP7
|
Lapatinib
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
|
Lapatinib + Chlorambucil
|
DCPB7SG
|
Lapatinib
|
Amelanotic melanoma (Cell Line: M14)
|
[5] |
|
Lapatinib + Chlorambucil
|
DC33JE6
|
Lapatinib
|
Glioma (Cell Line: SF-295)
|
[5] |
|
Lapatinib + Chlorambucil
|
DCIEWFW
|
Lapatinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
|
Lapatinib + Chlorambucil
|
DCMNJS3
|
Lapatinib
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
|
Lapatinib + Chlorambucil
|
DCYZ2NW
|
Lapatinib
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
|
Leflunomide + Chlorambucil
|
DC6Y73C
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Lenalidomide + Chlorambucil
|
DCK13H1
|
Lenalidomide
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Lenalidomide + Chlorambucil
|
DCIC8VD
|
Lenalidomide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Lenalidomide + Chlorambucil
|
DCD4B2T
|
Lenalidomide
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Lenalidomide + Chlorambucil
|
DCEVC42
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
|
Lenalidomide + Chlorambucil
|
DCORA7P
|
Lenalidomide
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
|
Lenalidomide + Chlorambucil
|
DCKFN3D
|
Lenalidomide
|
Melanoma (Cell Line: UACC-257)
|
[5] |
|
Lenalidomide + Chlorambucil
|
DC4SZTX
|
Lenalidomide
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Letrozole + Chlorambucil
|
DCX83QM
|
Letrozole
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Letrozole + Chlorambucil
|
DC1PW12
|
Letrozole
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Letrozole + Chlorambucil
|
DCF8BB1
|
Letrozole
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Letrozole + Chlorambucil
|
DC3Z92P
|
Letrozole
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Letrozole + Chlorambucil
|
DCTA8H9
|
Letrozole
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Letrozole + Chlorambucil
|
DC4EQ1N
|
Letrozole
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Letrozole + Chlorambucil
|
DC6SW1F
|
Letrozole
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Letrozole + Chlorambucil
|
DCJ8RR3
|
Letrozole
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[3] |
|
Letrozole + Chlorambucil
|
DCO2EUJ
|
Letrozole
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
LIAROZOLE + Chlorambucil
|
DC2GQ2D
|
LIAROZOLE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
LIAROZOLE + Chlorambucil
|
DCCPOD0
|
LIAROZOLE
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
LIAROZOLE + Chlorambucil
|
DCEWQIX
|
LIAROZOLE
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
LIAROZOLE + Chlorambucil
|
DCLCOAG
|
LIAROZOLE
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Loperamide + Chlorambucil
|
DCK588W
|
Loperamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Maprotiline + Chlorambucil
|
DCTKHG9
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Mecamylamine + Chlorambucil
|
DCKHSLF
|
Mecamylamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Mechlorethamine + Chlorambucil
|
DC4ZT4B
|
Mechlorethamine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
|
Mechlorethamine + Chlorambucil
|
DCPKUY2
|
Mechlorethamine
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
|
Mechlorethamine + Chlorambucil
|
DCVOLGN
|
Mechlorethamine
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
|
Mechlorethamine + Chlorambucil
|
DC4PQ9E
|
Mechlorethamine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
|
Mechlorethamine + Chlorambucil
|
DCTLNJB
|
Mechlorethamine
|
Melanoma (Cell Line: UACC-257)
|
[5] |
|
Mefloquine + Chlorambucil
|
DCTLSJ8
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Mepacrine + Chlorambucil
|
DCERFW1
|
Mepacrine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Mepacrine + Chlorambucil
|
DC3XCMO
|
Mepacrine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Mepacrine + Chlorambucil
|
DCF5EPM
|
Mepacrine
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Mepacrine + Chlorambucil
|
DC04QL2
|
Mepacrine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
|
Mepacrine + Chlorambucil
|
DCDKAYR
|
Mepacrine
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Mepacrine + Chlorambucil
|
DCTWEJ5
|
Mepacrine
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
|
Mepacrine + Chlorambucil
|
DCY5LOQ
|
Mepacrine
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
|
Mercaptopurine + Chlorambucil
|
DCJE8LT
|
Mercaptopurine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Mercaptopurine + Chlorambucil
|
DCYXOWY
|
Mercaptopurine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Mercaptopurine + Chlorambucil
|
DCDPIIM
|
Mercaptopurine
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Mercaptopurine + Chlorambucil
|
DCXKF4S
|
Mercaptopurine
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
|
Mercaptopurine + Chlorambucil
|
DCBIVCH
|
Mercaptopurine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
Mercaptopurine + Chlorambucil
|
DCVB0AJ
|
Mercaptopurine
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
|
Mercaptopurine + Chlorambucil
|
DC2VELU
|
Mercaptopurine
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
Methotrexate + Chlorambucil
|
DCUC9DF
|
Methotrexate
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Methotrexate + Chlorambucil
|
DCIZ233
|
Methotrexate
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Methylene blue + Chlorambucil
|
DCQ6SLO
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Mitomycin + Chlorambucil
|
DC3PNAT
|
Mitomycin
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Mitomycin + Chlorambucil
|
DCIFGGU
|
Mitomycin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Mitomycin + Chlorambucil
|
DCVIH93
|
Mitomycin
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
Mitomycin + Chlorambucil
|
DCC3NXO
|
Mitomycin
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
|
Mitomycin + Chlorambucil
|
DCGUZFY
|
Mitomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
Mitomycin + Chlorambucil
|
DCWKJPC
|
Mitomycin
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[5] |
|
Mycophenolic acid + Chlorambucil
|
DCONGZQ
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Nilotinib + Chlorambucil
|
DCV3Q8U
|
Nilotinib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Nilotinib + Chlorambucil
|
DCLBC8M
|
Nilotinib
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Nilotinib + Chlorambucil
|
DC90HL9
|
Nilotinib
|
Amelanotic melanoma (Cell Line: M14)
|
[5] |
|
Oxyphenbutazone + Chlorambucil
|
DC3Q8N8
|
Oxyphenbutazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Pargyline + Chlorambucil
|
DC435X2
|
Pargyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Pazopanib HCl + Chlorambucil
|
DCPIGJ2
|
Pazopanib HCl
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Pentostatin + Chlorambucil
|
DCI87NQ
|
Pentostatin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Pentostatin + Chlorambucil
|
DCA0453
|
Pentostatin
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Pentostatin + Chlorambucil
|
DCADHYK
|
Pentostatin
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Pentostatin + Chlorambucil
|
DCHX2PW
|
Pentostatin
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Pentostatin + Chlorambucil
|
DC0ZPO7
|
Pentostatin
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Picoplatin + Chlorambucil
|
DC8OJJG
|
Picoplatin
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Picoplatin + Chlorambucil
|
DC4NIDK
|
Picoplatin
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
|
Picoplatin + Chlorambucil
|
DCHYQ41
|
Picoplatin
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Picoplatin + Chlorambucil
|
DCSJHG6
|
Picoplatin
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
|
Picoplatin + Chlorambucil
|
DC4HK60
|
Picoplatin
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
|
Picoplatin + Chlorambucil
|
DCF36ES
|
Picoplatin
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
Picoplatin + Chlorambucil
|
DCJAVM4
|
Picoplatin
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Pinacidil + Chlorambucil
|
DCSUQ5J
|
Pinacidil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Plicamycin + Chlorambucil
|
DCFMYUH
|
Plicamycin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Plicamycin + Chlorambucil
|
DCY9LX0
|
Plicamycin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Plicamycin + Chlorambucil
|
DCBPG8U
|
Plicamycin
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Plicamycin + Chlorambucil
|
DC4T49Z
|
Plicamycin
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Plicamycin + Chlorambucil
|
DCDQ2K1
|
Plicamycin
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Plicamycin + Chlorambucil
|
DCV0MWR
|
Plicamycin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Plicamycin + Chlorambucil
|
DC8UGUM
|
Plicamycin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Plicamycin + Chlorambucil
|
DC0NGWR
|
Plicamycin
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
|
Plicamycin + Chlorambucil
|
DCZPIWH
|
Plicamycin
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
|
Plicamycin + Chlorambucil
|
DCLVOU2
|
Plicamycin
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCKZMUA
|
PMID28460551-Compound-2
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCH1X6Y
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DC0ZYLA
|
PMID28460551-Compound-2
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCRJXW5
|
PMID28460551-Compound-2
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCGOUL9
|
PMID28460551-Compound-2
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCY6FXB
|
PMID28460551-Compound-2
|
Melanoma (Cell Line: SK-MEL-2)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DCGXBLZ
|
PMID28460551-Compound-2
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[5] |
|
PMID28460551-Compound-2 + Chlorambucil
|
DC0UOZW
|
PMID28460551-Compound-2
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
|
PMID28870136-Compound-43 + Chlorambucil
|
DC0NNSD
|
PMID28870136-Compound-43
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
PMID28870136-Compound-43 + Chlorambucil
|
DC6W56Q
|
PMID28870136-Compound-43
|
Glioma (Cell Line: SF-295)
|
[3] |
|
PMID28870136-Compound-43 + Chlorambucil
|
DC2B3WR
|
PMID28870136-Compound-43
|
Renal cell carcinoma (Cell Line: SN12C)
|
[3] |
|
PMID28870136-Compound-43 + Chlorambucil
|
DC8UVPD
|
PMID28870136-Compound-43
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
PMID28870136-Compound-43 + Chlorambucil
|
DCZ765C
|
PMID28870136-Compound-43
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
|
Pomalidomide + Chlorambucil
|
DC2AOS7
|
Pomalidomide
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
Pomalidomide + Chlorambucil
|
DCKN8GK
|
Pomalidomide
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Pomalidomide + Chlorambucil
|
DCA9P34
|
Pomalidomide
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Pralatrexate + Chlorambucil
|
DCKTHMC
|
Pralatrexate
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Pralatrexate + Chlorambucil
|
DCC3W9C
|
Pralatrexate
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Pralatrexate + Chlorambucil
|
DC7KWU2
|
Pralatrexate
|
Adenocarcinoma (Cell Line: A549)
|
[5] |
|
Pralatrexate + Chlorambucil
|
DCV0NZT
|
Pralatrexate
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
|
Pralatrexate + Chlorambucil
|
DCU4PGP
|
Pralatrexate
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
|
Pralatrexate + Chlorambucil
|
DCEW6E0
|
Pralatrexate
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[5] |
|
Probenecid + Chlorambucil
|
DCV6ZFQ
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Raloxifene + Chlorambucil
|
DCE4KE4
|
Raloxifene
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Raloxifene + Chlorambucil
|
DCB4NKV
|
Raloxifene
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Raloxifene + Chlorambucil
|
DCUKUEO
|
Raloxifene
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Raloxifene + Chlorambucil
|
DCGOMH4
|
Raloxifene
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Raloxifene + Chlorambucil
|
DCD0K7C
|
Raloxifene
|
Adenocarcinoma (Cell Line: DU-145)
|
[5] |
|
Raloxifene + Chlorambucil
|
DC5QGL6
|
Raloxifene
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
|
Raloxifene + Chlorambucil
|
DC3YR8Q
|
Raloxifene
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Raloxifene + Chlorambucil
|
DC02QSM
|
Raloxifene
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[5] |
|
Raloxifene + Chlorambucil
|
DCFZEGY
|
Raloxifene
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
|
Raloxifene + Chlorambucil
|
DCBT3W2
|
Raloxifene
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
|
Raloxifene + Chlorambucil
|
DCC3ITE
|
Raloxifene
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
|
Raltegravir + Chlorambucil
|
DCESKH1
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Repaglinide + Chlorambucil
|
DC2LPW5
|
Repaglinide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Romidepsin + Chlorambucil
|
DC8L3IB
|
Romidepsin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Romidepsin + Chlorambucil
|
DCS1L2E
|
Romidepsin
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Romidepsin + Chlorambucil
|
DCI8JXC
|
Romidepsin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Romidepsin + Chlorambucil
|
DCTEUYO
|
Romidepsin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[5] |
|
Romidepsin + Chlorambucil
|
DC7E1JH
|
Romidepsin
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
|
Romidepsin + Chlorambucil
|
DCVGO4J
|
Romidepsin
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[5] |
|
Ruxolitinib + Chlorambucil
|
DCBVM8V
|
Ruxolitinib
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
|
SCH 727965 + Chlorambucil
|
DCS7XAD
|
SCH 727965
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
SCH 727965 + Chlorambucil
|
DC3NOJS
|
SCH 727965
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[5] |
|
SCH 727965 + Chlorambucil
|
DCWFX3A
|
SCH 727965
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
|
Sirolimus + Chlorambucil
|
DCDY1H4
|
Sirolimus
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Sirolimus + Chlorambucil
|
DC2ZB4F
|
Sirolimus
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Sirolimus + Chlorambucil
|
DCHE2VZ
|
Sirolimus
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[5] |
|
Sorafenib + Chlorambucil
|
DCP7QF6
|
Sorafenib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Sorafenib + Chlorambucil
|
DCIHDZV
|
Sorafenib
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
|
Sorafenib + Chlorambucil
|
DCFX6AO
|
Sorafenib
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
SY-1425 + Chlorambucil
|
DCM66MY
|
SY-1425
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
SY-1425 + Chlorambucil
|
DCV57AF
|
SY-1425
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
SY-1425 + Chlorambucil
|
DCSYR34
|
SY-1425
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
SY-1425 + Chlorambucil
|
DCOW8BR
|
SY-1425
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
|
SY-1425 + Chlorambucil
|
DCH409P
|
SY-1425
|
Adenocarcinoma (Cell Line: A549)
|
[5] |
|
SY-1425 + Chlorambucil
|
DCKM2K1
|
SY-1425
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
SY-1425 + Chlorambucil
|
DCW1X1L
|
SY-1425
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
|
SY-1425 + Chlorambucil
|
DCOY7KB
|
SY-1425
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
Taxol + Chlorambucil
|
DC3DISG
|
Taxol
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Taxol + Chlorambucil
|
DC54FI1
|
Taxol
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
TEM + Chlorambucil
|
DCUFPIS
|
TEM
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
TEM + Chlorambucil
|
DCN6U6C
|
TEM
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
|
TEM + Chlorambucil
|
DCEOJJ5
|
TEM
|
Glioma (Cell Line: SF-295)
|
[3] |
|
TEM + Chlorambucil
|
DCY79E3
|
TEM
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
TEM + Chlorambucil
|
DCBEJEF
|
TEM
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
TEM + Chlorambucil
|
DCF4CMO
|
TEM
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
TEM + Chlorambucil
|
DCY2W90
|
TEM
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[5] |
|
TEM + Chlorambucil
|
DCS0ZNS
|
TEM
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
|
TEM + Chlorambucil
|
DC67PDZ
|
TEM
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
|
TEM + Chlorambucil
|
DCC2IE2
|
TEM
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[5] |
|
TEM + Chlorambucil
|
DCJEQV9
|
TEM
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Terameprocol + Chlorambucil
|
DC8F6IM
|
Terameprocol
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Terameprocol + Chlorambucil
|
DC505UL
|
Terameprocol
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
Terameprocol + Chlorambucil
|
DCILGKY
|
Terameprocol
|
Adenocarcinoma (Cell Line: HT29)
|
[5] |
|
Thioguanine + Chlorambucil
|
DCRQCVA
|
Thioguanine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Thioguanine + Chlorambucil
|
DCVXYEO
|
Thioguanine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Thioguanine + Chlorambucil
|
DCB2BC4
|
Thioguanine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Thioguanine + Chlorambucil
|
DC0I6H1
|
Thioguanine
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Thioguanine + Chlorambucil
|
DCQZSDF
|
Thioguanine
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Thioguanine + Chlorambucil
|
DCHUDB6
|
Thioguanine
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Thioguanine + Chlorambucil
|
DCKEV10
|
Thioguanine
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Thioguanine + Chlorambucil
|
DCLTOFJ
|
Thioguanine
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
|
Thioguanine + Chlorambucil
|
DCECL80
|
Thioguanine
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Topetecan + Chlorambucil
|
DCBUDJA
|
Topetecan
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[5] |
|
Topetecan + Chlorambucil
|
DC7F6WB
|
Topetecan
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
|
Topotecan + Chlorambucil
|
DC6UKR0
|
Topotecan
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Topotecan + Chlorambucil
|
DCGXBMU
|
Topotecan
|
Astrocytoma (Cell Line: SNB-19)
|
[5] |
|
Topotecan + Chlorambucil
|
DCS089T
|
Topotecan
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[5] |
|
Topotecan + Chlorambucil
|
DCUAR0R
|
Topotecan
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[5] |
|
Topotecan + Chlorambucil
|
DCM0ZKX
|
Topotecan
|
Melanoma (Cell Line: MALME-3M)
|
[5] |
|
Topotecan + Chlorambucil
|
DCZIXZJ
|
Topotecan
|
Melanoma (Cell Line: UACC-257)
|
[5] |
|
Topotecan + Chlorambucil
|
DCHCMSY
|
Topotecan
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Topotecan + Chlorambucil
|
DCK7GDZ
|
Topotecan
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[5] |
|
Topotecan + Chlorambucil
|
DCIGNLJ
|
Topotecan
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
Topotecan + Chlorambucil
|
DC6LF8L
|
Topotecan
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[5] |
|
Triapine + Chlorambucil
|
DCL8CM6
|
Triapine
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Triapine + Chlorambucil
|
DC98DWD
|
Triapine
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
Triapine + Chlorambucil
|
DC8XS84
|
Triapine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[5] |
|
Triapine + Chlorambucil
|
DCQ9CFI
|
Triapine
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[5] |
|
Triflupromazine + Chlorambucil
|
DC4XXVH
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Trifluridine + Chlorambucil
|
DC91VF2
|
Trifluridine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Trifluridine + Chlorambucil
|
DCCJAHI
|
Trifluridine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Trifluridine + Chlorambucil
|
DCOIIXF
|
Trifluridine
|
Adenocarcinoma (Cell Line: NCIH23)
|
[5] |
|
Trifluridine + Chlorambucil
|
DCYI9HA
|
Trifluridine
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
|
Trifluridine + Chlorambucil
|
DCGX37L
|
Trifluridine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[5] |
|
Trifluridine + Chlorambucil
|
DCRAJGJ
|
Trifluridine
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[5] |
|
Trimethobenzamide + Chlorambucil
|
DCX5BIZ
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Uracil mustard + Chlorambucil
|
DCO121Y
|
Uracil mustard
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Uracil mustard + Chlorambucil
|
DCVW1T6
|
Uracil mustard
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Uracil mustard + Chlorambucil
|
DCQ5MS8
|
Uracil mustard
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Uracil mustard + Chlorambucil
|
DCBX4CU
|
Uracil mustard
|
Adenocarcinoma (Cell Line: HCT116)
|
[5] |
|
Valrubicin + Chlorambucil
|
DCFPZ4K
|
Valrubicin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Vemurafenib + Chlorambucil
|
DCXTBXS
|
Vemurafenib
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
Vemurafenib + Chlorambucil
|
DCBIXMG
|
Vemurafenib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[5] |
|
Vemurafenib + Chlorambucil
|
DCWJIMM
|
Vemurafenib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[5] |
|
Vemurafenib + Chlorambucil
|
DCHUYJ0
|
Vemurafenib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[5] |
|
Vemurafenib + Chlorambucil
|
DCGT4W1
|
Vemurafenib
|
Malignant melanoma (Cell Line: UACC62)
|
[5] |
|
Vemurafenib + Chlorambucil
|
DCF0X1E
|
Vemurafenib
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[5] |
|
Vincristine + Chlorambucil
|
DCR58C2
|
Vincristine
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Vincristine + Chlorambucil
|
DCQW9RN
|
Vincristine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Vinflunine + Chlorambucil
|
DCEGQA4
|
Vinflunine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Vinflunine + Chlorambucil
|
DCC1VOE
|
Vinflunine
|
Adenocarcinoma (Cell Line: HCT-15)
|
[5] |
|
Vismodegib + Chlorambucil
|
DC2MR13
|
Vismodegib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[5] |
|
Vismodegib + Chlorambucil
|
DCKLXF6
|
Vismodegib
|
Renal cell carcinoma (Cell Line: SN12C)
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
